A Novel Chemotherapeutic Drug Poly-L-Lysine against Cancer Therapy

A Research Based Study

von Tapan Kumar Chatterjee, Souvik Debnath

204 Seiten, Hardcover

Kurzbeschreibung des Verlags

"A Novel Chemotherapeutic Drug Poly-L-Lysine against Cancer Therapy - A Research based Study" offers a fresh perspective on cancer therapy. This research-based study delves into the potential of L-lysine as a novel chemotherapeutic drug that could revolutionize cancer treatment. The authors present the results of their studies which showcase Poly-L-lysine's anti-angiogenesis properties and its potential in treating angiogenesis-related diseases. The book features eleven comprehensive chapters that provide an in-depth analysis of the research including the apoptotic and anticancer effects of L-lysine in mice models as well as its anti-proliferative and antiangiogenic properties. At the same time the book shares fascinating insights about the history of cancer and the medical community's ongoing efforts to find a cure. A Novel Chemotherapeutic Drug Poly-L-Lysine against Cancer Therapy - A Research based Study" is a must-read for anyone interested in the latest advancements in cancer research and the future of cancer therapy.

• Themen: Medizin Klinische und Innere Medizin Krankheiten und Störungen Onkologie Chemotherapie / Pharmakotherapie
• ISBN: 9789390211784
• Sprache: Englisch
• Erscheinungsdatum: 01.10.2025
• Größe: 240 x 161 mm
• Verlag: PharmaMed Press